or
Bookmark and Share
Light imaging contrast agents
 
   
Document Number
US Patent 6540981
Issued Date
April 1, 2003
Link
Map
Abstract
The present invention relates to the use of particulate materials as contrast agents in in vivo light imaging.
Tags:
Description:
Amusing 0%
Clever 0%
Complex 0%
Efficient 0%
Historic 0%
Important 0%
Innovative 0%
Interesting 0%
Practical 0%
Simple 0%
Number of Claims:
31
Comments:
no comments yet
Owner
Published
April 1, 2003
Application Number
09/732,917
Filed
December 11, 2000
US Classification
424/9.6   424/9.1
Int'l Classification
A61K   49/00   (20060101)  
Attorney/Law Firm
Parent Case
RELATED APPLICATIONS This application is a continuation of U.S. application Ser. No. 08/984,771, filed Dec. 4, 1997, U.S. Pat. No. 6,159,445, which is a continuation-in-part of application Ser. No. 08/875,645 filed Jul. 31, 1997, now abandoned, as the US designation of International patent application No. PCT/GB96/00222 filed Feb. 2, 1996.
USPTO Field of Search
424/9.1   424/9.4   424/9.45   424/9.451   424/9.6   424/9.7   600/300   600/310   600/317  
Related Patents
7128894 - Contrast enhancing solution for use in confocal microscopy - Owned by The United States of America as represented by the United States Department of Energy (Washington, DC) N/A

A method of optically detecting a tumor during surgery. The method includes imaging at least one test point defined on the tumor using a first optical imaging system to provide a first tumor image. The method further includes excising a first predetermined layer of the tumor for forming an in-vivo defect area. A predetermined contrast enhancing solution is disposed on the in-vivo defect area, which is adapted to interact with at least one cell anomaly, such as basal cell carcinoma, located on the in-vivo defect area for optically enhancing the cell anomaly. Thereafter the defect area can be optically imaged to provide a clear and bright representation of the cell anomaly to aid a surgeon while surgically removing the cell anomaly.

Claims
Description
About| FAQs| Terms & Disclaimer| Link to Us| Contact Us